Artificial Intelligence (Ai)-Enabled Nanocarriers in Cancer Diagnosis Publisher



Hoseini ZS ; Najafi AM ; Rouzbahani FN ; Soriano RN ; Rahdar A
Source: Intelligent Nanocarriers: AI-Based Tools in Cancer Diagnosis and Therapy Published:2026

Abstract

In recent years, nanotechnology has significantly advanced, offering new methods for the early detection and treatment of cancer. Nanocarriers, utilized for precisely delivering drugs and cancer biomarkers to target cells, have revolutionized this field thanks to substantial progress in artificial intelligence (AI). AI algorithms, including machine learning and neural networks, process and analyze the data derived from these nanocarriers. This technology enhances molecular profiling precision, increases the speed and sensitivity of early cancer diagnosis, and aids clinicians in developing personalized and more effective treatments for cancer patients. These nanoparticles have the ability to detect biomolecules at extremely low concentrations, enabling the diagnosis of small tumors and early metastases. In addition, the capacity of artificial intelligence to analyze large datasets can increase the nanomedicines accuracy, contributing to the development of more effective, precise targeted nanomedicines, and reducing side effects. This chapter delves into the application of artificial intelligence in accurate cancer diagnosis, emphasizing the role of nanocarriers in cancer biomarker extraction and artificial intelligence-based advances in biosensing for cancer diagnosis. The synergy between nanotechnology and AI not only opens up new ways for cancer diagnosis and therapy, but also supports the emergence of more individualized treatment strategies. © 2026 Scrivener Publishing LLC.